Abstract. The case of a 7-year-old boy affected with precocious puberty and a large intra-and suprasellar pituitary tumour is described. He had hyperprolactinemia and elevated serum LH, FSH 
. Pituitary tumours rarely occur in childhood and adolescence and they are usually associated with delayed onset of puberty and hypogonadism (2) : these features have been particu¬ larly described in young patients with prolactinomas (3) and in one girl with LH-and PRL-secreting pituitary tumour (4) . So far, precocious pu¬ berty in patients with pituitary adenomas has been described, to our knowledge, in only two patients, one with a prolactinoma (5) and one with a LH-and PRL-producing tumour (6) .
In this paper we describe a 7-year-old boy with precocious puberty and a large pituitary tumour who had hyperprolactinemia and slightly elevated LH and FSH levels. Pre (Fig. 2) (Fig. 4, panel B (12) (13) (14) ; they mostly occur in adult males and cause hypogonadism. Also prolactinomas are related with de¬ ficiency of gonadal function in both adults (15) and adolescent patients (3) . On the contrary, the ap¬ pearance of precocious puberty has been reported, to our knowledge, in only two patients with pitu¬ itary tumours, a boy with an LH-and PRL-producing tumour (6) and another boy with a prolactinoma (5 (12, 16) .
The lack of influence of dopamine infusion on LH and FSH levels may possibly account for the negligible effect of chronic bromocriptine admin¬ istration on gonadotropins, indicating the value of the test in predicting the response to chronic dopaminergic treatment (17) . The effectiveness of bromocriptine therapy in patients with gonadotropin-secreting pituitary tumours is uncertain; in fact FSH and alpha-subunit levels can be reduced (17) (18) (19) , but an evident tumour shrinkage has not been observed (20, 21) .
Besides variable responsiveness to physiological agents, an abnormal hormonal reaction to a non¬ specific releasing hormone was observed in this pa¬ tient. An abnormal response to TRH has been found in about 80% of tested patients with gonadotropinomas (16, 19) . Although an increase in both gonadotropins is frequently induced by TRH in patients with only LH-or FSH-secreting tu¬ mours ( 16, 19) , a dissociation between the abnormal rise of the hypersecreted tropin and the absent re¬ sponse of the normally circulating gonadotropin has also been reported (16 (23) and of alphasubunit levels in another (18) has been already de¬ scribed, thus suggesting a possible usefulness of the test in patients with gonadotropinomas.
Aid ough an abnormal increase in gonadotropin levels during GnRH analogue treatment has been observed in few patients with gonadotropin-secreting adenoma (24, 25) , in the present case the GnRH analogue buserelin was able to lower LH and FSH levels, probably through a down-regula¬ tion mechanism, similar to that observed in normal subjects. The progressive increase in alpha-subunit levels during GnRH analogue treatment, as ob¬ served in girls with idiopathic precocious puberty (26) , indicates a different control of alpha-and beta-subunit synthesis by GnRH (27) . (7, 9, 29, 30) . In this adenoma the so far unreported association of PRL, LH and FSH in the same cell is clearly demonstrated and was the cause of the pre¬ cocious puberty of the boy; in fact the removal of the tumour led to a normalization of the endocrine function and to remission of the disease.
